Conserved and unique features of terminal telomeric sequences in ALT-positive cancer cells
eLife · 2025
DOI: 10.7554/elife.106657 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Benura Azeroglu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, United States. Hauptthemen laut MEDLINE: Telomere Homeostasis, Telomere, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
A significant portion of human cancers utilize a recombination-based pathway, alternative lengthening of telomeres (ALT), to maintain telomere length. Targeting the ALT is of growing interest as a cancer therapy, yet a substantial knowledge gap remains regarding the basic features of telomeres in ALT-positive cells. To address this, we adopted END-seq, an unbiased sequencing-based approach, to define the identity and regulation of the terminal sequences of chromosomes in ALT cells. Our data reveal that the terminal portions of chromosomes in ALT cells contain canonical telomeric sequences with the same terminus bias (-ATC) observed in non-ALT cells. Furthermore, as reported for non-ALT cells, POT1 is required to preserve the precise regulation of the 5′ end in cells that maintain telomere length using the ALT pathway. Thus, the regulation of the terminal 5′ of chromosomes occurs independently of the mechanism of telomere elongation. Additionally, we employed an S1 endonuclease-based sequencing method to determine the presence and origin of single-stranded regions within ALT telomeres. These data shed light on conserved and unique features of ALT telomeres.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, United States.
ORCID-Profile: Benura Azeroglu, Raphael Pavani, Ranjodh Singh Sandhu, Eros Lazzerini-Denchi
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Azeroglu, B., Wu, W., Pavani, R., Sandhu, R. S., Matsumoto, T., Nussenzweig, A., & Lazzerini-Denchi, E. (2025). Conserved and unique features of terminal telomeric sequences in ALT-positive cancer cells. eLife. https://doi.org/10.7554/elife.106657
Vancouver
Azeroglu B, Wu W, Pavani R, Sandhu RS, Matsumoto T, Nussenzweig A, et al. Conserved and unique features of terminal telomeric sequences in ALT-positive cancer cells. eLife. 2025. doi:10.7554/elife.106657
BibTeX
@article{Azeroglu2025,
author = {Azeroglu, Benura and Wu, Wei and Pavani, Raphael and Sandhu, Ranjodh Singh and Matsumoto, Tadahiko and Nussenzweig, André and Lazzerini-Denchi, Eros},
title = {Conserved and unique features of terminal telomeric sequences in ALT-positive cancer cells},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.106657}
}
EUVIMED